Regentis Biomaterials Ltd.
Industry
- Biotechnology
- Medical Devices
- Biomaterials
- Implantable Devices
- Pharmaceuticals
- Drug Delivery
See more in Biomedtracker
Latest on Regentis Biomaterials Ltd.
Medtech Insight
• By Reed Miller
US FDA has agreed to Regentis Biomaterials Ltd. 's plan to use an historical control, instead of a randomized control, in its pivotal trial of the GelrinC biodegradable hydrogel for the treatment
In Vivo
• By Amanda Micklus and Maureen Riordan
Device Transactions During the first quarter of 2016, device companies raised an aggregate $1.8 billion in financing, a 50% increase over last quarter's $1.2 billion. Debt was the top financing vehicl
Medtech Insight
Scrip
IN VITRO DIAGNOSTICS BioDirection Inc. BioDirection completes $4mm Series B round BioDirection Inc. (brain injury diagnostics) completed a $4mm Series B convertible preferred stock sale to Pro